Nutra Pharma Corp. Share Price Other OTC
Equities
NPHC
US67060U2087
Biotechnology & Medical Research
Sales 2020 | 51.9T 43.31L | Sales 2021 | 97.74T 81.56L | Capitalization | 1.47Cr 122.27Cr |
---|---|---|---|---|---|
Net income 2020 | - 0 | Net income 2021 | -1.3Cr -108.48Cr | EV / Sales 2020 | 238 x |
Net Debt 2020 | 52.39L 44Cr | Net Debt 2021 | 83.04L 69Cr | EV / Sales 2021 | 235 x |
P/E ratio 2020 |
-10.3
x | P/E ratio 2021 |
-1.1
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 62 | 27/16/27 | |
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 07/02/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 07/02/07 |
Stewart Lonky
BRD | Director/Board Member | 75 | 05/04/05 |
Garry Pottruck
BRD | Director/Board Member | 65 | 29/09/29 |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 4.95TCr | |
+1.00% | 4.26TCr | |
+49.39% | 4.25TCr | |
-5.26% | 2.91TCr | |
+13.68% | 2.66TCr | |
-22.99% | 1.86TCr | |
+8.22% | 1.32TCr | |
+32.41% | 1.25TCr | |
+24.01% | 1.21TCr |